{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["van der Linden RJ"],"funding":["NIA NIH HHS","NIMH NIH HHS","NINDS NIH HHS","National Institutes of Health"],"pagination":["102316"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9912016"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["217"],"pubmed_abstract":["The RNA binding protein ELAVL4/HuD regulates the translation and splicing of multiple Alzheimer's disease (AD) candidate genes. We generated ELAVL4 knockout (KO) human induced pluripotent stem cell-derived neurons to study the effect that ELAVL4 has on AD-related cellular phenotypes. ELAVL4 KO significantly increased the levels of specific APP isoforms and intracellular phosphorylated tau, molecular changes that are related to the pathological hallmarks of AD. Overexpression of ELAVL4 in wild-type neurons and rescue experiments in ELAVL4 KO cells showed opposite effects and also led to a reduction of the extracellular amyloid-beta (Aβ)42/40 ratio. All these observations were made in familial AD (fAD) and fAD-corrected neurons. To gain insight into the molecular cascades involved in neurona"],"journal":["Progress in neurobiology"],"pubmed_title":["RNA-binding protein ELAVL4/HuD ameliorates Alzheimer's disease-related molecular changes in human iPSC-derived neurons."],"pmcid":["PMC9912016"],"funding_grant_id":["RF1 NS117446","R01 MH101148","R01AG055909","R01 AG055909","R01NS117446"],"pubmed_authors":["White FM","Widomska J","Poelmans G","Franke B","Gerritsen JS","Young-Pearse TL","van der Linden RJ","Liao M","Pearse RV"],"additional_accession":[]},"is_claimable":false,"name":"RNA-binding protein ELAVL4/HuD ameliorates Alzheimer's disease-related molecular changes in human iPSC-derived neurons.","description":"The RNA binding protein ELAVL4/HuD regulates the translation and splicing of multiple Alzheimer's disease (AD) candidate genes. We generated ELAVL4 knockout (KO) human induced pluripotent stem cell-derived neurons to study the effect that ELAVL4 has on AD-related cellular phenotypes. ELAVL4 KO significantly increased the levels of specific APP isoforms and intracellular phosphorylated tau, molecular changes that are related to the pathological hallmarks of AD. Overexpression of ELAVL4 in wild-type neurons and rescue experiments in ELAVL4 KO cells showed opposite effects and also led to a reduction of the extracellular amyloid-beta (Aβ)42/40 ratio. All these observations were made in familial AD (fAD) and fAD-corrected neurons. To gain insight into the molecular cascades involved in neurona","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Oct","modification":"2025-04-04T03:00:48.853Z","creation":"2025-04-04T03:00:48.853Z"},"accession":"S-EPMC9912016","cross_references":{"pubmed":["35843356"],"doi":["10.1016/j.pneurobio.2022.102316"]}}